Manufacturing method of microporous titanium metatarsal bone implant

Through personalized design and finite element analysis, the microporous titanium metatarsal implants are optimized, and the problem of limited donor and implant mismatch in traditional bone defect treatment methods is solved, achieving higher osseous integration and quality of life Improvement reduces the patient's pain and speeds up the recovery process.

CN118949124APending Publication Date: 2024-11-15ZIGONG NO 4 PEOPLES HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411176445.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-11-15

AI Technical Summary

Technical Problem

Traditional bone defect treatment methods such as bone grafts and metal implants have problems such as limited donor locations, rejection reactions, mismatch between the implant and the human bones and poor corrosion resistance, which affects the patient's functional recovery and quality of life.

Method used

Using the production method of microporous titanium metatarsal implants, three-dimensional reconstruction of CT scan data, finite element analysis optimization, rapid electron beam molten metal molding, constant potential anodization treatment and phosphate conversion membrane modification, combined with polyethylene seed bone Prosthesis, designed personalized titanium metatarsal implants, enhance osteocyte growth and bone integration, and reduce skin compression of metal prosthesis.

Benefits of technology

Achieve better matching of titanium metatarsal implants with the patient's bones, improve initial stability and long-term osteointegration, reduce patient pain, accelerate rehabilitation process, improve quality of life, and improve drug layer assisted treatment and anti-inflammatory regulation. Effectiveness.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118949124A_ABST
    Figure CN118949124A_ABST
Patent Text Reader

Abstract

The invention provides a manufacturing method of a microporous titanium metatarsal bone implant, and belongs to the technical field of biomedical engineering and orthopedic implantation. The method comprises the following steps: collecting foot CT scanning data of a patient, generating personalized 3D models of a first metatarsal bone and an inner side cuneiform bone by using a mirror image technology, performing finite element analysis optimization, manufacturing a titanium metatarsal bone implant by using an electron beam molten metal rapid prototyping system and Ti6Al4V powder, and finally implanting a prosthesis into the foot of the patient through an operation. The implant can be better matched with the bone of a patient, higher initial stability and long-term osseointegration are provided, and through personalized design and finite element analysis optimization, the implant can relieve pain of the patient, accelerate the rehabilitation process and improve the living quality of the patient, and the patient can have a good application prospect. The metatarsal bone implant can assist in treatment and operation to improve the curative effect by adhering the medicine to the surface of the metatarsal bone implant, the corrosion resistance of the metatarsal bone implant is improved through electrochemical anodic oxidation, and the comprehensive performance such as biological activity and biocompatibility of the metatarsal bone implant is enhanced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of biomedical engineering and orthopedic implant technology, and in particular to a method for manufacturing a microporous titanium metal metatarsal implant. Background Art

[0002] Large metatarsal bone defects are common problems in orthopedic clinics. Trauma and tumors are common causes, which bring great pain to patients and affect their daily activities. Traditional treatment methods such as fibula bone bridging transplantation and bone filling titanium mesh have certain limitations, such as limited donor sites, rejection reactions, and mismatch between implants and human bones, which seriously affect the postoperative function of patients. Therefore, it is crucial to develop a new treatment plan.

[0003] Existing treatment methods such as bone transplantation and metal implants have certain limitations, such as limited donor sites, mismatch between implants and human bones, poor corrosion resistance of implants and susceptibility to inflammation. Therefore, the present application provides a method for manufacturing a microporous titanium metatarsal implant to meet the needs. Summary of the invention

[0004] 1. Technical issues to be resolved

[0005] In view of the deficiencies of the prior art, the present invention provides a method for manufacturing a microporous titanium metatarsal implant, which solves certain limitations of traditional treatment methods, such as limited donor sites, rejection reactions, and mismatch between implants and human bones.

[0006] (II) Technical solution

[0007] In order to solve the above technical problems, the present invention provides the following technical solution: a method for manufacturing a microporous titanium metal metatarsal implant, comprising the following steps:

[0008] Step 1: Collect data, collect the patient's foot CT scan data and perform three-dimensional reconstruction;

[0009] Step 2: Generate the model. Use the patient's healthy foot structure data to generate a 3D model of the first metatarsal and medial cuneiform through mirror technology and perform pre-optimization.

[0010] Step 3: Optimize the model, establish a foot model in the finite element analysis software, perform stress and displacement analysis on the model, perform topology optimization, and obtain the optimized model;

[0011] Step 4: Manufacturing metatarsal implants: import the optimized model into the electron beam melting metal rapid prototyping system, use Ti6Al4V powder as the printing material, manufacture titanium metatarsal implants, and then clean and polish them;

[0012] Step 5: performing a constant potential anodizing treatment on the surface of the metatarsal implant, and then placing the treated metatarsal implant in a mussel adhesive protein solution for dip coating to form a film;

[0013] Step 6: immersing the metatarsal implant in a phosphate conversion solution containing soluble salts of trace elements, first performing ultrasonic treatment at 55 to 75° C., and then performing static treatment to obtain a phosphate conversion film layer containing trace elements on the surface of the titanium metal, and then placing the treated metatarsal implant in a dopamine hydrochloride solution for reaction to obtain a polydopamine-modified titanium metal containing a phosphate film layer of trace elements;

[0014] Step 7: Immerse the treated titanium metal in an exosome suspension for incubation to obtain a titanium implant capable of slowly releasing trace elements and exosomes; in a phosphate conversion solution containing soluble salts of trace elements;

[0015] Step 8: Use polyethylene material to make polyethylene sesamoid implants through CNC processing and install them with titanium metatarsal implants through embedding and pressing to reduce the local pressure of the metal prosthesis on the skin during walking;

[0016] Preferably, the surface of the titanium metatarsal implant is designed with micropores to enhance bone cell growth and bone integration.

[0017] Preferably, a plurality of locking holes are provided on the surface of the titanium metal metatarsal bone near the inner side, the diameter of the locking holes is 3.5 mm, and the locking holes are used for locking screws.

[0018] Preferably, a connection hole is opened on the surface of the titanium metal metatarsal bone, the diameter of the connection hole is 1 mm, and the connection hole is connected by a ligament.

[0019] Preferably, a porous prosthesis stem is provided at the right end of the titanium metal metatarsal, and the porous prosthesis stem is used to be inserted into a bony structure. A reinforcing rib is provided at the left end of the titanium metal metatarsal, and the reinforcing rib is used to enhance the strength of the titanium metal metatarsal.

[0020] Preferably, a polyethylene sesamoid bone prosthesis is provided at the right end of the titanium metal metatarsal, and a porous contact surface is provided on the surface of the titanium metal metatarsal near the inner side, and the porous contact surface is used to promote bone ingrowth.

[0021] Preferably, the trace element is one or more of Fe, Zn, Sr, Al, Mg, Mn, and Zr, the concentration of calcium nitrate is 0.02 to 0.2 mol / L, the concentration of dihydrogen phosphate ion is 0.05 to 0.5 mol / L, the concentration of sodium nitrate is 0.01 to 0.03 mol / L, and the concentration of trace element ions is 0.001 to 0.2 mol / L.

[0022] Preferably, a drug layer is provided on the surface of the porous contact surface layer, and the drug layer is adhered to the surface of the porous contact surface layer via an adhesive layer, and the adhesive layer is a bioadhesive layer.

[0023] Preferably, the mussel adhesive protein film layer is diluted with citric acid to 0.05 to 3 mg / mL, and the pH is adjusted to 3 to 6; the titanium metal metatarsal is dipped in the mussel adhesive protein solution for 0.5 to 4 hours.

[0024] Preferably, before the titanium metal metatarsal surface is subjected to constant potential anodizing treatment, the titanium metal metatarsal is first immersed in acetone, ethanol and deionized water for ultrasonic cleaning, and then placed in a mixed acid solution of HNO3 and HF for etching, rinsing and drying.

[0025] Compared with the prior art, the present invention has at least the following beneficial effects:

[0026] In the above scheme, the implant can better match the patient's bones, provide higher initial stability and long-term bone integration. Through personalized design and finite element analysis optimization, the implant of the present invention can relieve the patient's pain, speed up the recovery process, and improve the patient's quality of life.

[0027] By bonding drugs to the surface of metatarsal implants, auxiliary treatment and surgery can be used to improve the efficacy. Electrochemical anodization can be used to improve the corrosion resistance of metatarsal implants and enhance the comprehensive properties of metatarsal implants, such as bioactivity and biocompatibility. Exosomes can be released synchronously with the degradation of the phosphate film layer in the body, exerting anti-inflammatory, immune regulation, and promoting vascularization and osteogenesis.

[0028] In summary, the present invention has the advantages of alleviating the patient's pain, accelerating the recovery process, and improving the patient's quality of life. BRIEF DESCRIPTION OF THE DRAWINGS

[0029] Figure 1 This is a schematic diagram of clinical data of microporous titanium metatarsal implants;

[0030] Figure 2 Schematic diagram of the modeling structure of the microporous titanium metatarsal implant;

[0031] Figure 3 It is a schematic diagram of the structure of a microporous titanium metal metatarsal implant;

[0032] Figure 4 Schematic diagram of the fabrication of a microporous titanium metatarsal implant;

[0033] Figure 5 Schematic diagram of sesamoid bone implant

[0034] Figure 6 Schematic diagram of microporous titanium metatarsal implant surgery.

[0035] As shown in the figure, in order to clearly implement the structure of the embodiment of the present invention, specific structures and devices are marked in the figure, but this is only for illustrative purposes and is not intended to limit the present invention to the specific structure, device and environment. According to specific needs, ordinary technicians in this field can adjust or modify these devices and environments. DETAILED DESCRIPTION

[0036] The following is a detailed description of the method for making the microporous titanium metatarsal implant provided by the present invention in conjunction with the accompanying drawings and specific embodiments. At the same time, it is explained here that in order to make the embodiments more detailed, the following embodiments are the best and preferred embodiments, and those skilled in the art may also adopt other alternatives to implement some known technologies; and the accompanying drawings are only for a more specific description of the embodiments, and are not intended to specifically limit the present invention.

[0037] It should be noted that the references to "one embodiment", "embodiment", "exemplary embodiments", "some embodiments" and the like in the specification indicate that the embodiments described may include specific features, structures or characteristics, but not every embodiment may include the specific features, structures or characteristics. In addition, when a specific feature, structure or characteristic is described in conjunction with an embodiment, it should be within the knowledge of a person skilled in the art to implement such feature, structure or characteristic in conjunction with other embodiments (whether or not explicitly described).

[0038] In general, a term can be understood, at least in part, from its use in context. For example, depending, at least in part, on the context, the term "one or more" as used herein can be used to describe any feature, structure, or characteristic in the singular sense, or can be used to describe a combination of features, structures, or characteristics in the plural sense. Additionally, the term "based on" can be understood as not necessarily intended to convey an exclusive set of factors, but can instead, depending, at least in part, on the context, allow for the presence of other factors that are not necessarily explicitly described.

[0039] It will be understood that the meanings of “on,” “over,” and “above” in the present invention should be interpreted in the broadest manner, so that “on” not only means “directly on” something, but also includes the meaning of being “on” something with intervening features or layers therebetween, and “on” or “over” not only means “on” or “above” something, but also includes the meaning of being “on” or “above” something with no intervening features or layers therebetween.

[0040] Additionally, spatially relative terms such as "under," "beneath," "lower," "above," "upper," and the like may be used herein for descriptive convenience to describe the relationship of one element or feature to another element or features, as shown in the accompanying drawings. Spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the accompanying drawings. The device may be oriented in other ways, and the spatially relative descriptors used herein may be similarly interpreted accordingly.

[0041] like Figures 1 to 3 As shown, an embodiment of the present invention provides a method for manufacturing a microporous titanium metatarsal implant, wherein the surface of the titanium metatarsal implant is designed with micropores to enhance the growth of bone cells and bone integration, a plurality of locking holes are opened on the surface of the titanium metatarsal near the inner side, the diameter of the locking holes is 3.5 mm, and the locking holes are used to lock screws, a connecting hole is opened on the surface of the titanium metatarsal, the diameter of the connecting hole is 1 mm, and the connecting holes are connected by ligaments, a porous prosthesis stem is provided at the right end of the titanium metatarsal, and the porous prosthesis stem is used to insert into the bony structure, a reinforcing rib is opened at the left end of the titanium metatarsal, and the reinforcing rib is used to enhance the strength of the titanium metatarsal, a polyethylene sesamoid prosthesis is provided at the right end of the titanium metatarsal, a porous contact surface is opened on the surface of the titanium metatarsal near the inner side, and the porous contact surface is used to promote bone ingrowth, clinical data: a 58-year-old male patient with a height of 158 cm was diagnosed with traumatic bone defects of the first metatarsal and the medial cuneiform. After orderly debridement, bone cement placement and filling, and anterior and lateral thigh free flap transplantation, such as Figure 1 The patient had difficulty walking after bone cement filling and requested another surgery. The symmetry, range of motion, nerve response and blood vessels of the bilateral ankle joints were examined; the bone defect was initially confirmed by X-ray, and a CT scan was subsequently performed, and the image was reconstructed in three dimensions using Dicom format data. The CT images of both feet were imported into Mimics22.0.

[0042] The first model scheme: Generate a metatarsal implant model by mirroring the healthy part of the patient, and design the screw holes and prosthesis stem, which is defined as model A. Figure 2 A, B. The volume of model A is V1. The volume of the bone cement filled on the affected side of the patient before the second surgery is V2. Model A was pre-optimized using Geomagic Wrap 2021 and SolidWorks 2017. A static finite element model of a normal foot was established in ANSYS Workbench 19.1, as shown in Figure 2. Figure 3A. The foot and model A were defined as isotropic materials with the same elastic modulus and Poisson's ratio parameters. In order to improve the accuracy of the finite element model, second-order tetrahedral elements were used for meshing. The mesh size of the bone was controlled at 2 to 3 mm, while the mesh size of model A, screws, model A to bone contact, and screw to bone contact was controlled at 1 to 1.5 mm. After multiple iterations, the average skewness of the prosthesis finite element model was reduced to within 0.5. The contact interfaces of bone to bone, screw to bone, prosthesis to bone, and prosthesis to screw were set as binding relationships. In the standing position, the angle between the first metatarsal and the horizontal plane is 30°. During gait, this angle increases to 70°, and the internal stress of the first metatarsal reaches the maximum. One of the finite element analysis projects set model A to a 30° angle between the first metatarsal and the horizontal plane, such as Figure 3 B. At this point, a vertical force of 500 N was applied to the talar surface, with the fixation points being the base of the calcaneal tuberosity, the sesamoid prosthesis, and the fifth metatarsal head. Another finite element analysis project set model A to a 70° angle between the first metatarsal and the horizontal plane, such as Figure 3 C. At this time, a force of 500 N is applied to the talar surface in the direction of prosthesis A, with the fixation points being the sesamoid prosthesis and the fifth metatarsal head.

[0043] The two finite element analysis results of model A were topologically optimized respectively. In the optimization area setting, the contact interface between the prosthesis and the bone, the screw holes and the prosthesis stem were set as "exclusion areas", while the rest of the prosthesis was designated as the "design area". The optimization type was set to "level set-based topology optimization", and the optimization goal was to retain the volume of V2 (refer to the bone cement filling volume of the first surgery). The topology optimization results of model A in two directions were exported as two STL files through Ansys software. Then a Boolean merge operation was performed on these models in 3-Matic. The comprehensive model obtained after smoothing correction was labeled as model B, as shown in Figure 2 C and D, the volume is approximately within ±5% of V2. Model B was then analyzed in Ansys software using the same settings as model A to evaluate the stress and displacement of the prosthesis.

[0044] The prosthesis consists of two parts: a titanium metatarsal and a polyethylene sesamoid prosthesis, connected by a locking structure. The surface of the titanium metatarsal is designed with micropores. There are prosthesis stems at both ends of the metatarsal to connect with the navicular bone and the first metatarsal. In addition, five holes with a diameter of 3.5mm are designed for locking screws to enhance the initial stability of the prosthesis. A total of 18 small holes are designed on the surface of the titanium metatarsal to connect ligaments, such as Figure 2 E, F.

[0045] The second model scheme: the metatarsal implant model generated by the above scheme 1 was used, and the metatarsal implant shaft was extended by 0.5 cm to match different surgical situations.

[0046] The third model scheme: the metatarsal implant model generated by the above scheme 1 is used, and the metatarsal implant shaft is reduced by 0.5 cm to match different surgical situations.

[0047] For the universal metatarsal implant, the metatarsal implant model was generated by mirroring the healthy part of the patient, and the screw holes and prosthesis stem were designed, which was defined as Model A. The volume of Model A was V1. The volume of the patient's affected side filled with bone cement before the second surgery was V2. Model A was pre-optimized using Geomagic Wrap 2021 and SolidWorks 2017. A static finite element model of a normal foot was established in ANSYS Workbench 19.1. The foot and Model A were defined as isotropic materials with the same elastic modulus and Poisson's ratio parameters. In order to improve the accuracy of the finite element model, second-order tetrahedral elements were used for meshing. The mesh size of the bone was controlled at 2 to 3 mm, while the mesh size of Model A, screw, Model A to bone contact, and screw to bone contact was controlled at 1.5 to 2 mm. After multiple iterations, the average skewness of the prosthesis finite element model was reduced to less than 0.5. The contact interfaces of bone to bone, screw to bone, prosthesis to bone, and prosthesis to screw were set as binding relationships. In the standing position, the first metatarsal is at an angle of 35° to the horizontal plane. During gait, this angle increases to 75°, and the internal stress of the first metatarsal reaches its maximum. One of the finite element analysis projects sets Model A to an angle of 35° between the first metatarsal and the horizontal plane. At this time, a vertical force of 500 N is applied to the surface of the talus, and the fixed points are the bottom of the calcaneal tuberosity, the sesamoid prosthesis, and the fifth metatarsal head. Another finite element analysis project sets Model A to an angle of 75° between the first metatarsal and the horizontal plane. At this time, a force of 500 N is applied to the surface of the talus in the direction of prosthesis A, and the fixed points are the sesamoid prosthesis and the fifth metatarsal head. Topological optimization was performed on the two finite element analysis results of Model A. In the optimization region settings, the contact interface between the prosthesis and the bone, the screw holes, and the prosthesis stem were set as "exclusion regions", while the rest of the prosthesis was designated as "design regions". The optimization type was set to "level set-based topology optimization", and the optimization goal was to preserve the volume of V2, referring to the bone cement filling volume of the first surgery. The topology optimization results of model A in both directions were exported as two STL files through Ansys software. These models were then Boolean merged in 3-Matic. The integrated model obtained after smoothing correction was labeled as model B, and the volume was approximately within V2±5%. Model B was then analyzed in Ansys software using the same settings as model A to evaluate the stress and displacement of the prosthesis, and the parameters could be adjusted according to the patient data.

[0048] In this embodiment, the trace elements are one or more of Fe, Zn, Sr, Al, Mg, Mn, and Zr, the concentration of calcium nitrate is 0.02 to 0.2 mol / L, the dihydrogen phosphate ion is 0.05 to 0.5 mol / L, the sodium nitrate is 0.01 to 0.03 mol / L, the concentration of trace element ions is 0.001 to 0.2 mol / L, a drug layer is provided on the surface of the porous contact surface layer, and the drug layer is bonded to the surface of the porous contact surface layer through an adhesive layer, the adhesive layer is a bioadhesive layer, and the mussel adhesion protein film layer is diluted with citric acid to 0.05 to 3 mg / mL, and the pH is adjusted to 3 to 6; the titanium metatarsal is dipped in the mussel adhesion protein solution for 0.5 to 4 hours, and before the surface of the titanium metatarsal is subjected to constant potential anodizing treatment, the titanium metatarsal is first immersed in acetone, ethanol and deionized water for ultrasonic cleaning, and then placed in a mixed acid solution of HNO3 and HF for etching and rinsing and drying.

[0049] The metatarsal implant, model B, was introduced into the electron beam molten metal rapid prototyping system. The printing material was Ti6Al4V powder with an average diameter of 45 to 105 μm. The maximum scanning speed of the electron beam was 8000 ms to 1, and the printing accuracy was ±0.2 mm. The metatarsal implant was cleaned in the powder recovery system and cleaned with acetone, ethanol and distilled water in an ultrasonic machine for 30 minutes respectively. The sesamoid prosthesis was manufactured by computer numerical control. The material was polyethylene. Highly cross-linked polyethylene was used to increase the wear resistance of the sesamoid prosthesis. This treatment not only improved the wear resistance of polyethylene, but also reduced its friction coefficient. In addition, the use of polyethylene prosthesis can make the postoperative effect more natural without obvious step feeling, which enhances the aesthetics of the surgery. Figure 5 As shown, the surface of the prosthesis is polished to make it smooth, the front and back of model B are shown in Figure 4As shown in the figure, the corrosion resistance of metatarsal implants was improved by electrochemical anodization, and then a mussel adhesive protein film was prepared on the surface of the metatarsal implant by electrochemical deposition and impregnation self-assembly. The mussel adhesive protein film can optimize the preferred growth direction and multi-level ordered structure of the calcium phosphate film layer, and significantly enhance the comprehensive properties of the metatarsal implant, such as bioactivity and biocompatibility. A phosphate conversion solution containing strontium was prepared, and the concentrations of each component were 0.05 mol / LCa2·4H2O, 0.1 mol / L SrCl2·6H2O, 0.15mol / L NaH2PO4·2H2O and 0.02mol / L NaNO3, the pH value was adjusted to 4.75, the metatarsal implant after grinding, cleaning and acid pickling was immersed in the solution, reacted for 30min under ultrasonic field water bath conditions at 70°C, then allowed to stand in a water bath for 30min, washed and dried to obtain a phosphate film layer modified with strontium trace elements on the surface of the metatarsal implant, and then treated with a pH value of 8.5% tris-HCl Tris-HCl was used to prepare a 2 mg / mL dopamine hydrochloride solution, the metatarsal implant was immersed in the solution, and the reaction was carried out under light-proof conditions for 18 h. After that, the implant was taken out and repeatedly rinsed with flowing deionized water to remove the unbound polydopamine. After drying, the polydopamine-modified metatarsal implant was obtained. Rat bone marrow mesenchymal stem cells were cultured in serum-free medium to P3 to P5 generations. After 48 to 72 h, the conditioned medium was collected, the supernatant was collected by filtration, and the supernatant was centrifuged at 3000 g for 10 min at 4 ° C to remove dead cells and cell debris, etc. ExoQuick-T was added at a ratio of medium: reagent = 5:1. C exosome precipitate, vortex to mix it thoroughly, incubate at 4 ° C for 12 hours, then centrifuge the mixture at 10000g for 60 minutes at 4 ° C, discard the supernatant, obtain the precipitate rich in exosome particles, take 400 μL PBS buffer and blow the precipitate evenly, transfer it to a new centrifuge tube after it is evenly suspended in PBS, and centrifuge it at 12000g for 2 minutes at 4 ° C to obtain the crude exosome particles. The harvested crude product is transferred to the upper chamber of the purification column, centrifuged at 3000g for 10 minutes at 4 ° C, and the liquid at the bottom of the purification column tube is collected to obtain the purified exosome suspension. The metatarsal implant is placed in a 24-well plate In each well, 10 μL of exosome suspension was injected, mixed and incubated in a shaker at 4°C in the dark for 12 h, and finally metatarsal implants modified with trace element phosphate conversion membrane and exosomes were obtained. Exosomes can be released synchronously with the degradation of the phosphate membrane layer in vivo, playing anti-inflammatory, immune regulation, promoting vascularization, and promoting osteogenesis. The main chemical component of the phosphate membrane layer on the titanium surface is calcium phosphate doped with trace metal elements, which can be slowly degraded in the in vivo environment. The degradation can be accelerated under the acidic pH conditions of the inflammatory environment at the beginning of implantation, releasing Ca2+ and PO43 to the titanium implant material and the surrounding bone tissue, transporting nutrients for bone matrix deposition, and forming a firm bond with the bone tissue. The chemical bonding of the adhesive will not affect the drug's properties, but can also dissolve and release the drug in human tissue. In addition, the production method of sequentially setting the adhesive layer and the drug layer in the metatarsal implant has a very high production efficiency. The bioadhesive has the usual bonding function and the special biomedical function. It is safe, reliable, non-toxic to the human body, has good biocompatibility, has no stimulation, and can be gradually degraded, absorbed and metabolized. Among them, the bioadhesive layer can be made of fibrinogen, thrombin, muscle adhesive protein, casein, chitin, chitosan, natural or modified polysaccharides, polyethylene glycol derivatives or starch, etc.

[0050] like Figure 6 As shown, in this embodiment, the titanium metatarsal and polyethylene sesamoid prostheses are sterilized before the operation, the patient is placed in a supine position, the ankle and foot areas are sterilized after general anesthesia, and the skin and soft tissues are cut open to completely expose the surgical area, as shown in FIG. Figure 6A, The deep structures were exposed after incision of subcutaneous fat and the bone cement filler was removed, e.g. Figure 6 B, Drilling is performed with the aid of a 3D-printed navigation template to facilitate implantation of the prosthesis stem. Figure 6 C, implantation of the proximal stem, such as Figure 6 D, Locking screw fixation and ligament reconstruction to confirm implant stability, e.g. Figure 6 E, Appearance of the affected limb 1 week after surgery. Figure 6 F.

[0051] The method for making a microporous titanium metatarsal implant comprises the following steps when in use;

[0052] Step 1: Collect data: collect the patient's foot CT scan data and perform three-dimensional reconstruction;

[0053] Step 2: Generate a model. Use the patient's healthy foot structure data to generate a 3D model of the first metatarsal and medial cuneiform through mirror technology and perform pre-optimization.

[0054] Step 3: Optimize the model, establish a foot model in the finite element analysis software, perform stress and displacement analysis on the model, perform topology optimization, and obtain the optimized model;

[0055] Step 4: Manufacturing a metatarsal implant, importing the optimized model into an electron beam melting metal rapid prototyping system, using Ti6Al4V powder as a printing material, manufacturing a titanium metatarsal implant, and then cleaning and polishing it;

[0056] Step 5, subjecting the surface of the metatarsal implant to a constant potential anodizing treatment, and then placing the treated metatarsal implant in a mussel adhesive protein solution for dip coating to form a film;

[0057] Step 6: Immerse the metatarsal implant in a phosphate conversion solution containing soluble salts of trace elements, perform ultrasonic treatment at 55 to 75° C., and then perform static treatment to obtain a phosphate conversion film layer containing trace elements on the surface of the titanium metal, and then place the treated metatarsal implant in a dopamine hydrochloride solution for reaction to obtain a polydopamine-modified titanium metal containing a trace element phosphate film layer;

[0058] Step 7: Immerse the treated titanium metal in an exosome suspension for incubation to obtain a titanium implant capable of slowly releasing trace elements and exosomes; in a phosphate conversion solution containing soluble salts of trace elements;

[0059] Step 8: Use polyethylene material to make polyethylene sesamoid implants through CNC processing and install them with titanium metatarsal implants through embedding and pressing to reduce the local pressure of the metal prosthesis on the skin during walking;

[0060] The technical solution provided by the present invention is as follows: the image is three-dimensionally reconstructed through Dicom format data, the CT images of both feet are imported into Mimics 22.0, the metatarsal implant model is generated by mirroring the healthy part of the patient, and the screw holes and the prosthesis stem are designed, which is defined as model A, such as Figure 2 A and B. The volume of model A is V1, and the volume of bone cement filled on the affected side of the patient before the second surgery is V2. Model A was pre-optimized using Geomagic Wrap 2021 and SolidWorks 2017, and a static finite element model of a normal foot was established in ANSYS Workbench 19.1, as shown in Figure 2. Figure 3 A, the foot and model A were defined as isotropic materials with the same elastic modulus and Poisson's ratio parameters. In order to improve the accuracy of the finite element model, second-order tetrahedral elements were used for meshing. The mesh size of the bone was controlled at 2 to 3 mm, while the mesh sizes of model A, screws, model A to bone contact, and screw to bone contact were controlled at 1 to 1.5 mm. After multiple iterations, the average skewness of the prosthesis finite element model was reduced to less than 0.5. The contact interfaces of bone to bone, screw to bone, prosthesis to bone, and prosthesis to screw were set as binding relationships. In the standing position, the angle between the first metatarsal and the horizontal plane was 30°. During gait, this angle increased to 70°, and the internal stress of the first metatarsal reached the maximum. One of the finite element analysis projects set model A to a 30° angle between the first metatarsal and the horizontal plane, as shown in Figure 2. Figure 3 B. At this time, a vertical force of 500 N was applied to the surface of the talus. The fixation points were at the base of the calcaneal tuberosity, the sesamoid prosthesis, and the head of the fifth metatarsal. Another finite element analysis project set model A to a 70° angle between the first metatarsal and the horizontal plane, as shown in Figure 3 C. At this time, a force of 500 N was applied to the talar surface along the direction of prosthesis A. The fixed points were the sesamoid prosthesis and the fifth metatarsal head. The two finite element analysis results of model A were topologically optimized. In the optimization area setting, the contact interface between the prosthesis and the bone, the screw holes and the prosthesis stem were set as "exclusion areas", while the rest of the prosthesis was designated as "design area". The optimization type was set to "level set-based topology optimization". The optimization goal was to retain the volume of V2. Referring to the bone cement filling volume of the first surgery, the topology optimization results of model A in both directions were exported as two STL files through Ansys software, and then the models were Boolean merged in 3-Matic. The comprehensive model obtained after smoothing correction was marked as model B, as shown in Figure 2. Figure 2C, D, the volume is approximately within V2±5%. Model B was then analyzed in Ansys software using the same settings as model A to evaluate the stress and displacement of the prosthesis. The prosthesis consists of two parts: a titanium metatarsal and a polyethylene sesamoid prosthesis, which are connected by a locking structure. The surface of the titanium metatarsal is designed with micropores. Both ends of the metatarsal have prosthetic stems to connect with the navicular bone and the first metatarsal. In addition, five holes with a diameter of 3.5 mm are designed for locking screws to enhance the initial stability of the prosthesis. A total of 18 small holes are designed on the surface of the titanium metatarsal to connect the ligaments, such as Figure 2 E, F, The metatarsal implant, model B, was introduced into the electron beam molten metal rapid prototyping system. The printing material was Ti6Al4V powder with an average diameter of 45 to 105 μm. The maximum scanning speed of the electron beam was 8000 ms to 1, and the printing accuracy was ±0.2 mm. The metatarsal implant was cleaned in the powder recovery system and cleaned in an ultrasonic machine with acetone, ethanol, and distilled water for 30 minutes respectively. The sesamoid prosthesis was manufactured by computer numerical control and the material was polyethylene, such as Figure 5 As shown, the surface of the prosthesis is polished to make it smooth, the front and back of model B are shown in Figure 4As shown in the figure, the corrosion resistance of metatarsal implants was improved by electrochemical anodization, and then a mussel adhesive protein film was prepared on the surface of the metatarsal implant by electrochemical deposition and impregnation self-assembly. The mussel adhesive protein film can optimize the preferred growth direction and multi-level ordered structure of the calcium phosphate film layer, and significantly enhance the comprehensive properties of the metatarsal implant, such as bioactivity and biocompatibility. A phosphate conversion solution containing strontium was prepared, and the concentrations of each component were 0.05 mol / LCa2·4H2O, 0.1 mol / L SrCl2·6H2O, 0.15mol / L NaH2PO4·2H2O and 0.02mol / L NaNO3, the pH value was adjusted to 4.75, the metatarsal implant after grinding, cleaning and acid pickling was immersed in the solution, reacted for 30min under ultrasonic field water bath conditions at 70°C, then allowed to stand in a water bath for 30min, washed and dried to obtain a phosphate film layer modified with strontium trace elements on the surface of the metatarsal implant, and then treated with a pH value of 8.5% tris-HCl Tris-HCl was used to prepare a 2 mg / mL dopamine hydrochloride solution, the metatarsal implant was immersed in the solution, and the reaction was carried out at 37°C in the dark for 18 hours, then taken out, and repeatedly rinsed with flowing deionized water to remove unbound polydopamine. After drying, the polydopamine-modified metatarsal implant was obtained. Rat bone marrow mesenchymal stem cells were cultured in serum-free medium to P3 to P5 generations. After 48 to 72 hours, the conditioned medium was collected, the supernatant was collected by filtration, and the supernatant was centrifuged at 3000g for 10 minutes at 4°C to remove dead cells and cell debris, etc. ExoQuick-TC exosome precipitation solution was added at a ratio of medium: reagent = 5:1, and vortexed to fully Mix well, incubate at 4°C for 12 hours, then centrifuge the mixture at 10000g for 60min at 4°C, discard the supernatant, obtain the precipitate rich in exosome particles, take 400μL PBS buffer and blow the precipitate evenly, transfer it to a new centrifuge tube after it is evenly suspended in PBS, centrifuge at 12000g for 2min at 4°C to obtain the crude exosome particles, transfer the harvested crude product to the upper chamber of the purification column, centrifuge at 3000g for 10min at 4°C, collect the liquid at the bottom of the purification column, and obtain the purified exosome suspension. Place the metatarsal implant in a 24-well plate, inject 10μL of the exosome suspension into each well, mix and incubate in a shaker at 4°C in the dark. After 12 hours, the metatarsal implant modified with trace element phosphate conversion film and exosomes was finally obtained. The exosomes can be released synchronously with the degradation of the phosphate film layer in vivo, and play anti-inflammatory, immune regulation, vascularization and osteogenesis effects. The main chemical component of the phosphate film layer on the titanium surface is calcium phosphate doped with trace metal elements, which can be slowly degraded in the body environment. The degradation can be accelerated under acidic pH conditions of the inflammatory environment at the beginning of implantation, and Ca2+ and PO43 are released to the titanium implant material and the surrounding bone tissue to transport nutrients for bone matrix deposition and form a strong chemical bond with the bone tissue. The bonding method will not only not affect the medicinal properties of the drug, but also dissolve and release the drug in the human tissue. The production method of setting the adhesive layer and the drug layer in the bone implant in vitro has a very high production efficiency, and the bioadhesive has the usual bonding function and the special biomedical function, is safe, reliable, non-toxic to the human body, has good biocompatibility, has no stimulation and can be gradually degraded, absorbed and metabolized. Among them, the bioadhesive layer can be selected from fibrinogen, thrombin, muscle adhesive protein, casein, chitin, chitosan, natural or modified polysaccharides, polyethylene glycol derivatives or starch, etc., by disinfecting the titanium metatarsal and polyethylene sesamoid prostheses, the patient takes the supine position, disinfects the ankle and foot areas after general anesthesia, and the skin and soft tissue are cut open to completely expose the surgical area, such as. Figure 6 A, The deep structures were exposed after incision of subcutaneous fat and the bone cement filler was removed, e.g. Figure 6B, Drilling is performed with the aid of a 3D-printed navigation template to facilitate implantation of the prosthesis stem. Figure 6 C, implantation of the proximal stem, such as Figure 6 D, Locking screw fixation and ligament reconstruction to confirm implant stability, e.g. Figure 6 E, Appearance of the affected limb 1 week after surgery. Figure 6 F.

[0061] The present invention covers any substitution, modification, equivalent method and scheme made on the essence and scope of the present invention. In order to make the public have a thorough understanding of the present invention, specific details are described in detail in the following preferred embodiments of the present invention, and those skilled in the art can fully understand the present invention without the description of these details. In addition, in order to avoid unnecessary confusion about the essence of the present invention, well-known methods, processes, procedures, components and circuits are not described in detail.

[0062] The above is only a preferred embodiment of the present invention. It should be pointed out that for ordinary technicians in this technical field, several improvements and modifications can be made without departing from the principle of the present invention. These improvements and modifications should also be regarded as the scope of protection of the present invention.

Claims

1. Method for making microporous titanium metatarsal implant, It is characterized in that The following steps are involved: Step 1: Collect data, collect the patient's foot CT scan data and perform three-dimensional reconstruction; Step 2: Generate the model. Use the patient's healthy foot structure data to generate a 3D model of the first metatarsal and medial cuneiform through mirror technology and perform pre-optimization. Step 3: Optimize the model, establish a foot model in the finite element analysis software, perform stress and displacement analysis on the model, perform topology optimization, and obtain the optimized model; Step 4: Manufacturing metatarsal implants: import the optimized model into the electron beam melting metal rapid prototyping system, use Ti6Al4V powder as the printing material, manufacture titanium metatarsal implants, and then clean and polish them; Step 5: performing a constant potential anodizing treatment on the surface of the metatarsal implant, and then placing the treated metatarsal implant in a mussel adhesive protein solution for dip coating to form a film; Step 6: immersing the metatarsal implant in a phosphate conversion solution containing soluble salts of trace elements, first performing ultrasonic treatment at 55 to 75° C., and then performing static treatment to obtain a phosphate conversion film layer containing trace elements on the surface of the titanium metal, and then placing the treated metatarsal implant in a dopamine hydrochloride solution for reaction to obtain a polydopamine-modified titanium metal containing a phosphate film layer of trace elements; Step 7: Immerse the treated titanium metal in an exosome suspension for incubation to obtain a titanium implant capable of slowly releasing trace elements and exosomes; in a phosphate conversion solution containing soluble salts of trace elements; Step 8: Use polyethylene material to make polyethylene sesamoid implants through CNC processing and install them with titanium metatarsal implants through embedding and pressing to reduce the local pressure of the metal prosthesis on the skin during walking; Step 9: Implantation: A titanium metatarsal and polyethylene sesamoid prosthesis is surgically implanted in the patient's foot.

2. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that The titanium metatarsal implant is designed with micropores on its surface to enhance bone cell growth and bone integration.

3. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that A plurality of locking holes are provided on the surface of the titanium metal metatarsal bone near the inner side, the diameter of the locking holes is 3.5 mm, and the locking holes are used for locking screws.

4. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that A connection hole is opened on the surface of the titanium metal metatarsal bone, the diameter of the connection hole is 1 mm, and the connection hole is connected by a ligament.

5. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that The head and tail ends of the titanium metal metatarsal implant are provided with porous prosthesis stems, which are used to be inserted into the head and tail bone structures. The proximal end of the titanium metal metatarsal is provided with reinforcing ribs, which are used to enhance the strength of the titanium metal metatarsal.

6. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that A polyethylene sesamoid bone prosthesis is arranged on the plantar side of the titanium metal metatarsal head, and a porous contact surface is arranged on the surface of the titanium metal metatarsal bone near the inner side, and the porous contact surface is used to promote bone ingrowth.

7. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that The trace elements are one or more of Fe, Zn, Sr, Al, Mg, Mn, and Zr, the concentration of calcium nitrate is 0.02 to 0.2 mol / L, the concentration of dihydrogen phosphate ions is 0.05 to 0.5 mol / L, the concentration of sodium nitrate is 0.01 to 0.03 mol / L, and the concentration of trace element ions is 0.001 to 0.2 mol / L.

8. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that The surface of the porous contact surface layer is provided with a drug layer, and the drug layer is adhered to the surface of the porous contact surface layer through an adhesive layer, and the adhesive layer is a bioadhesive layer.

9. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that The mussel adhesive protein film layer is diluted with citric acid to 0.05 to 3 mg / mL, and the pH is adjusted to 3 to 6; the titanium metal metatarsal is dipped in the mussel adhesive protein solution for 0.5 to 4 hours.

10. The method for manufacturing the microporous titanium metatarsal implant according to claim 1, It is characterized in that Before the titanium metal metatarsal surface is subjected to constant potential anodizing treatment, the titanium metal metatarsal is first immersed in acetone, ethanol and deionized water for ultrasonic cleaning, and then placed in a mixed acid solution of HNO3 and HF for etching, washing and drying.